---

$26.33

+0.3500 ( +0.77% ) 11.6K

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Analyst Insights

---

You need to login to view this content.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-07-23	Sale	-45000.00	Schimmelpennink Evert B.
2024-05-15	Buy	3188.00	Chevallard Daniel R.
2024-05-14	Buy	31332.00	MCCOLLUM JAMES W
2024-03-25	Buy	2386301.00	RA CAPITAL MANAGEMENT, L.P.

Reset

Symbol	Issuer Name	Market Value ↓	Share Quantity
No records found.